(MedPage Today) — The FDA approved fitusiran (Qfitlia) as prophylaxis to prevent or reduce bleeding episodes in adults and children ages 12 years and up with hemophilia A or B, with or without factor VIII or IX inhibitors.
“Today’s approval of…
Source link : https://www.medpagetoday.com/hematologyoncology/hemophilia/114878
Author :
Publish date : 2025-03-28 20:16:00
Copyright for syndicated content belongs to the linked Source.
